Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2003 1
2005 5
2006 6
2007 9
2008 4
2009 9
2010 11
2011 15
2012 9
2013 12
2014 9
2015 11
2016 10
2017 9
2018 8
2019 10
2020 13
2021 11
2022 7
2023 8
2024 5

Text availability

Article attribute

Article type

Publication date

Search Results

158 results

Results by year

Filters applied: . Clear all
Page 1
Midostaurin plus Chemotherapy for Acute Myeloid Leukemia with a FLT3 Mutation.
Stone RM, Mandrekar SJ, Sanford BL, Laumann K, Geyer S, Bloomfield CD, Thiede C, Prior TW, Döhner K, Marcucci G, Lo-Coco F, Klisovic RB, Wei A, Sierra J, Sanz MA, Brandwein JM, de Witte T, Niederwieser D, Appelbaum FR, Medeiros BC, Tallman MS, Krauter J, Schlenk RF, Ganser A, Serve H, Ehninger G, Amadori S, Larson RA, Döhner H. Stone RM, et al. Among authors: mandrekar sj. N Engl J Med. 2017 Aug 3;377(5):454-464. doi: 10.1056/NEJMoa1614359. Epub 2017 Jun 23. N Engl J Med. 2017. PMID: 28644114 Free PMC article. Clinical Trial.
Ibrutinib Regimens versus Chemoimmunotherapy in Older Patients with Untreated CLL.
Woyach JA, Ruppert AS, Heerema NA, Zhao W, Booth AM, Ding W, Bartlett NL, Brander DM, Barr PM, Rogers KA, Parikh SA, Coutre S, Hurria A, Brown JR, Lozanski G, Blachly JS, Ozer HG, Major-Elechi B, Fruth B, Nattam S, Larson RA, Erba H, Litzow M, Owen C, Kuzma C, Abramson JS, Little RF, Smith SE, Stone RM, Mandrekar SJ, Byrd JC. Woyach JA, et al. Among authors: mandrekar sj. N Engl J Med. 2018 Dec 27;379(26):2517-2528. doi: 10.1056/NEJMoa1812836. Epub 2018 Dec 1. N Engl J Med. 2018. PMID: 30501481 Free PMC article. Clinical Trial.
Midostaurin reduces relapse in FLT3-mutant acute myeloid leukemia: the Alliance CALGB 10603/RATIFY trial.
Larson RA, Mandrekar SJ, Huebner LJ, Sanford BL, Laumann K, Geyer S, Bloomfield CD, Thiede C, Prior TW, Döhner K, Marcucci G, Voso MT, Klisovic RB, Galinsky I, Wei AH, Sierra J, Sanz MA, Brandwein JM, de Witte T, Niederwieser D, Appelbaum FR, Medeiros BC, Tallman MS, Krauter J, Schlenk RF, Ganser A, Serve H, Ehninger G, Amadori S, Gathmann I, Döhner H, Stone RM. Larson RA, et al. Among authors: mandrekar sj. Leukemia. 2021 Sep;35(9):2539-2551. doi: 10.1038/s41375-021-01179-4. Epub 2021 Mar 2. Leukemia. 2021. PMID: 33654204 Free PMC article. Clinical Trial.
Impact of NPM1/FLT3-ITD genotypes defined by the 2017 European LeukemiaNet in patients with acute myeloid leukemia.
Döhner K, Thiede C, Jahn N, Panina E, Gambietz A, Larson RA, Prior TW, Marcucci G, Jones D, Krauter J, Heuser M, Voso MT, Ottone T, Nomdedeu JF, Mandrekar SJ, Klisovic RB, Wei AH, Sierra J, Sanz MA, Brandwein JM, de Witte T, Jansen JH, Niederwieser D, Appelbaum FR, Medeiros BC, Tallman MS, Schlenk RF, Ganser A, Serve H, Ehninger G, Amadori S, Gathmann I, Benner A, Pallaud C, Stone RM, Döhner H, Bloomfield CD. Döhner K, et al. Among authors: mandrekar sj. Blood. 2020 Jan 30;135(5):371-380. doi: 10.1182/blood.2019002697. Blood. 2020. PMID: 31826241 Free PMC article.
Guidelines for Statistical Reporting in Medical Journals.
Ou FS, Le-Rademacher JG, Ballman KV, Adjei AA, Mandrekar SJ. Ou FS, et al. Among authors: mandrekar sj. J Thorac Oncol. 2020 Nov;15(11):1722-1726. doi: 10.1016/j.jtho.2020.08.019. Epub 2020 Aug 25. J Thorac Oncol. 2020. PMID: 32858236 Free PMC article. Review.
Clinical trial designs incorporating predictive biomarkers.
Renfro LA, Mallick H, An MW, Sargent DJ, Mandrekar SJ. Renfro LA, et al. Among authors: mandrekar sj. Cancer Treat Rev. 2016 Feb;43:74-82. doi: 10.1016/j.ctrv.2015.12.008. Epub 2016 Jan 5. Cancer Treat Rev. 2016. PMID: 26827695 Free PMC article. Review.
Statistical Considerations for Subgroup Analyses.
Wang X, Piantadosi S, Le-Rademacher J, Mandrekar SJ. Wang X, et al. Among authors: mandrekar sj. J Thorac Oncol. 2021 Mar;16(3):375-380. doi: 10.1016/j.jtho.2020.12.008. Epub 2020 Dec 26. J Thorac Oncol. 2021. PMID: 33373692 Free PMC article. No abstract available.
Statistical Models in Clinical Studies.
Matsui S, Le-Rademacher J, Mandrekar SJ. Matsui S, et al. Among authors: mandrekar sj. J Thorac Oncol. 2021 May;16(5):734-739. doi: 10.1016/j.jtho.2021.02.021. Epub 2021 Feb 26. J Thorac Oncol. 2021. PMID: 33647505 Free PMC article.
Precision oncology: A new era of cancer clinical trials.
Renfro LA, An MW, Mandrekar SJ. Renfro LA, et al. Among authors: mandrekar sj. Cancer Lett. 2017 Feb 28;387:121-126. doi: 10.1016/j.canlet.2016.03.015. Epub 2016 Mar 14. Cancer Lett. 2017. PMID: 26987624 Free PMC article. Review.
158 results